Vannice, Kirsten S.
Hills, Susan L.
Schwartz, Lauren M.
Barrett, Alan D.
Heffelfinger, James
Hombach, Joachim
Letson, G. William
Solomon, Tom
Marfin, Anthony A.
,
Anderson, Katie
Fischer, Marc
Fox, Kim
Jacobson, Julie
Liyanage, Jayantha
Marks, Florian
Ogbuanu, Ike
Tharmaphornpilas, Piyanit
Funding for this research was provided by:
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
Article History
Received: 27 July 2020
Accepted: 15 April 2021
First Online: 15 June 2021
Competing interests
: No conflicts of interest: G.W.L., J.M.H., J.H., S.H., L.M.S., K.V., A.A.M. T.S. is supported by the National Institute for Health Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections (Grant No. IS-HPU-1112-10117), NIHR Global Health Research Group on Brain Infections (No. 17/63/110), and the European Union’s Horizon 2020 research and innovation program ZikaPLAN (Preparedness Latin America Network), grant agreement No. 734584. A.D.T.B. is Editor in Chief of <i>npj Vaccines</i>.